UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2015
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _________to_________
Commission File Number
000-19932
RELIV’ INTERNATIONAL, INC.
(Exact name of Registrant as specified in its charter)
| Delaware | 371172197 | |
| (State or other jurisdiction of | (I.R.S. Employer Identification Number) | |
| incorporation or organization) | ||
| 136 Chesterfield Industrial Boulevard | ||
| Chesterfield, Missouri | 63005 | |
| (Address of principal executive offices) | (Zip Code) |
(636) 537-9715
(Registrant’s telephone number, including area code)
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company þ
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
The number of shares outstanding of the Registrant’s common stock as of November 2, 2015 was 12,919,110 (excluding treasury shares).
INDEX
PART I -- FINANCIAL INFORMATION
Item No. 1 - Financial Statements
Reliv International, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
| September 30 | December 31 | |||||||
| 2015 | 2014 | |||||||
| (unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 3,158,965 | $ | 4,989,392 | ||||
| Accounts receivable, less allowances of | ||||||||
| $30,200 in 2015 and $26,300 in 2014 | 84,536 | 265,530 | ||||||
| Accounts and note due from employees and distributors | 132,786 | 121,208 | ||||||
| Inventories | ||||||||
| Finished goods | 4,042,963 | 3,782,171 | ||||||
| Raw materials | 1,438,039 | 1,216,031 | ||||||
| Sales aids and promotional materials | 138,485 | 179,263 | ||||||
| Total inventories | 5,619,487 | 5,177,465 | ||||||
| Refundable income taxes | 472,157 | 257,577 | ||||||
| Prepaid expenses and other current assets | 771,657 | 661,038 | ||||||
| Deferred income taxes | 72,000 | 61,000 | ||||||
| Total current assets | 10,311,588 | 11,533,210 | ||||||
| Other assets | 272,682 | 295,929 | ||||||
| Cash surrender value of life insurance | 2,823,160 | 2,747,944 | ||||||
| Note receivable due from distributor | 1,656,449 | 1,732,982 | ||||||
| Deferred income taxes | 714,000 | 686,000 | ||||||
| Intangible assets, net | 2,723,179 | 2,925,775 | ||||||
| Property, plant and equipment: | ||||||||
| Land and land improvements | 893,735 | 883,563 | ||||||
| Building | 9,951,393 | 9,966,748 | ||||||
| Machinery & equipment | 4,350,849 | 4,355,040 | ||||||
| Office equipment | 1,223,983 | 1,235,192 | ||||||
| Computer equipment & software | 2,337,873 | 2,505,229 | ||||||
| 18,757,833 | 18,945,772 | |||||||
| Less: Accumulated depreciation | 12,183,081 | 12,019,802 | ||||||
| Net property, plant and equipment | 6,574,752 | 6,925,970 | ||||||
| Total assets | $ | 25,075,810 | $ | 26,847,810 | ||||
See notes to financial statements.
| 1 |
Reliv International, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
| September 30 | December 31 | |||||||
| 2015 | 2014 | |||||||
| (unaudited) | ||||||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses: | ||||||||
| Trade accounts payable and other accrued expenses | $ | 2,348,308 | $ | 2,026,198 | ||||
| Distributors' commissions payable | 1,588,129 | 1,753,908 | ||||||
| Sales taxes payable | 225,884 | 292,188 | ||||||
| Payroll, payroll taxes, and incentive compensation payable | 324,539 | 1,114,763 | ||||||
| Total accounts payable and accrued expenses | 4,486,860 | 5,187,057 | ||||||
| Current portion of long-term debt | 813,560 | 697,423 | ||||||
| Total current liabilities | 5,300,420 | 5,884,480 | ||||||
| Noncurrent liabilities: | ||||||||
| Revolving line of credit | - | 500,000 | ||||||
| Long-term debt, less current portion | 3,279,589 | 3,047,267 | ||||||
| Other noncurrent liabilities | 377,825 | 418,785 | ||||||
| Total noncurrent liabilities | 3,657,414 | 3,966,052 | ||||||
| Stockholders' equity: | ||||||||
| Preferred stock, par value $.001 per share; 3,000,000 | ||||||||
| shares authorized; -0- shares issued and outstanding | ||||||||
| in 2015 and 2014 | - | - | ||||||
| Common stock, par value $.001 per share; 30,000,000 | ||||||||
| authorized; 14,773,083 shares issued and 12,919,110 | ||||||||
| shares outstanding as of 9/30/2015; 14,673,083 shares | ||||||||
| issued and 12,819,110 shares outstanding as of 12/31/2014 | 14,773 | 14,673 | ||||||
| Additional paid-in capital | 30,484,480 | 30,321,598 | ||||||
| Accumulated deficit | (8,453,145 | ) | (7,434,595 | ) | ||||
| Accumulated other comprehensive loss: | ||||||||
| Foreign currency translation adjustment | (589,572 | ) | (565,838 | ) | ||||
| Treasury stock | (5,338,560 | ) | (5,338,560 | ) | ||||
| Total stockholders' equity | 16,117,976 | 16,997,278 | ||||||
| Total liabilities and stockholders' equity | $ | 25,075,810 | $ | 26,847,810 | ||||
See notes to financial statements.
| 2 |
Reliv International, Inc. and Subsidiaries
Condensed Consolidated Statements of Net
Income (Loss) and Comprehensive Income (Loss)
| (unaudited) | Three months ended September 30 | Nine months ended September 30 | ||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Product sales | $ | 11,250,271 | $ | 13,206,275 | $ | 36,401,384 | $ | 39,867,425 | ||||||||
| Handling & freight income | 944,182 | 1,108,006 | 3,072,783 | 3,387,322 | ||||||||||||
| Net sales | 12,194,453 | 14,314,281 | 39,474,167 | 43,254,747 | ||||||||||||
| Costs and expenses: | ||||||||||||||||
| Cost of products sold | 2,603,167 | 2,968,139 | 8,245,871 | 8,855,401 | ||||||||||||
| Distributor royalties and commissions | 4,308,647 | 4,985,450 | 14,048,971 | 15,425,704 | ||||||||||||
| Selling, general and administrative | 5,659,989 | 6,133,040 | 18,244,930 | 19,390,732 | ||||||||||||
| Total costs and expenses | 12,571,803 | 14,086,629 | 40,539,772 | 43,671,837 | ||||||||||||
| Income (loss) from operations | (377,350 | ) | 227,652 | (1,065,605 | ) | (417,090 | ) | |||||||||
| Other income (expense): | ||||||||||||||||
| Interest income | 28,536 | 31,736 | 88,991 | 100,008 | ||||||||||||
| Interest expense | (36,814 | ) | (26,054 | ) | (87,502 | ) | (75,689 | ) | ||||||||
| Other income / (expense) | (72,373 | ) | (60,372 | ) | (227,434 | ) | (53,983 | ) | ||||||||
| Income (loss) before income taxes | (458,001 | ) | 172,962 | (1,291,550 | ) | (446,754 | ) | |||||||||
| Provision (benefit) for income taxes | (169,000 | ) | 7,000 | (273,000 | ) | (173,000 | ) | |||||||||
| Net income (loss) | $ | (289,001 | ) | $ | 165,962 | $ | (1,018,550 | ) | $ | (273,754 | ) | |||||
| Other comprehensive income (loss): | ||||||||||||||||
| Foreign currency translation adjustment | (72,673 | ) | (57,101 | ) | (23,734 | ) | (17,194 | ) | ||||||||
| Comprehensive income (loss) | $ | (361,674 | ) | $ | 108,861 | $ | (1,042,284 | ) | $ | (290,948 | ) | |||||
| Earnings (loss) per common share - Basic | $ | (0.02 | ) | $ | 0.01 | $ | (0.08 | ) | $ | (0.02 | ) | |||||
| Weighted average shares | 12,919,000 | 12,666,000 | 12,853,000 | 12,666,000 | ||||||||||||
| Earnings (loss) per common share - Diluted | $ | (0.02 | ) | $ | 0.01 | $ | (0.08 | ) | $ | (0.02 | ) | |||||
| Weighted average shares | 12,919,000 | 12,750,000 | 12,853,000 | 12,666,000 | ||||||||||||
| Cash dividends declared per common share | $ | - | $ | - | $ | - | $ | - | ||||||||
See notes to financial statements.
| 3 |
Reliv International, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(unaudited)
| Nine months ended September 30 | ||||||||
| 2015 | 2014 | |||||||
| Operating activities: | ||||||||
| Net loss | $ | (1,018,550 | ) | $ | (273,754 | ) | ||
| Adjustments to reconcile net loss to | ||||||||
| net cash used in operating activities: | ||||||||
| Depreciation and amortization | 758,564 | 725,584 | ||||||
| Stock-based compensation | 45,981 | 36,178 | ||||||
| Non-cash life insurance policy accretion | (75,216 | ) | (66,248 | ) | ||||
| Deferred income taxes | (89,000 | ) | (142,000 | ) | ||||
| Foreign currency transaction (gain)/loss | 98,172 | 56,195 | ||||||
| (Increase) decrease in accounts receivable and accounts due | ||||||||
| from employees and distributors | 163,256 | (96,078 | ) | |||||
| (Increase) decrease in inventories | (585,634 | ) | 79,760 | |||||
| (Increase) decrease in refundable income taxes | (214,378 | ) | (234,219 | ) | ||||
| (Increase) decrease in prepaid expenses | ||||||||
| and other current assets | (123,423 | ) | (190,337 | ) | ||||
| (Increase) decrease in other assets | 23,247 | (11,501 | ) | |||||
| Increase (decrease) in income taxes payable | - | (199,558 | ) | |||||
| Increase (decrease) in accounts payable & accrued expenses | ||||||||
| and other noncurrent liabilities | (86,860 | ) | (403,554 | ) | ||||
| Net cash used in operating activities | (1,103,841 | ) | (719,532 | ) | ||||
| Investing activities: | ||||||||
| Proceeds from the sale of property, plant and equipment | 7,181 | 1,200 | ||||||
| Purchase of property, plant and equipment | (224,719 | ) | (511,227 | ) | ||||
| Payments received on distributor note receivable | 72,088 | 67,900 | ||||||
| Payment of life insurance premiums | - | (252,250 | ) | |||||
| Net cash used in investing activities | (145,450 | ) | (694,377 | ) | ||||
| Financing activities: | ||||||||
| Proceeds from line of credit borrowings | - | 500,000 | ||||||
| Repayment of line of credit borrowings | (500,000 | ) | - | |||||
| Proceeds from term loan borrowings | 3,249,501 | - | ||||||
| Principal payments on long-term borrowings | (3,334,552 | ) | (508,899 | ) | ||||
| Net cash used in financing activities | (585,051 | ) | (8,899 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents | 3,915 | (55,391 | ) | |||||
| Increase (decrease) in cash and cash equivalents | (1,830,427 | ) | (1,478,199 | ) | ||||
| Cash and cash equivalents at beginning of period | 4,989,392 | 6,656,798 | ||||||
| Cash and cash equivalents at end of period | $ | 3,158,965 | $ | 5,178,599 | ||||
| Supplementary disclosure of cash flow information: | ||||||||
| Noncash financing transactions (Note 5): | ||||||||
| Issuance of promissory notes | $ | 424,000 | $ | - | ||||
| Issuance of company common stock | $ | 117,000 | $ | - | ||||
See notes to financial statements.
| 4 |
Reliv International, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
September 30, 2015
| Note 1-- | Accounting Policies |
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which management believes are necessary to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2014, filed March 24, 2015 with the Securities and Exchange Commission.
Certain reclassifications have been made to 2014 amounts within the condensed consolidated statements of cash flows in order to conform to the current year presentation.
| Note 2-- | Basic and Diluted Earnings (Loss) per Share |
Basic earnings (loss) per common share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock.
The following table sets forth the computation of basic and diluted earnings (loss) per share:
| Three months ended September 30 | Nine months ended September 30 | |||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Numerator: | ||||||||||||||||
| Net income (loss) | $ | (289,001 | ) | $ | 165,962 | $ | (1,018,550 | ) | $ | (273,754 | ) | |||||
| Denominator: | ||||||||||||||||
| Denominator for basic earnings (loss) per | ||||||||||||||||
| share--weighted average shares | 12,919,000 | 12,666,000 | 12,853,000 | 12,666,000 | ||||||||||||
| Dilutive effect of employee stock options | ||||||||||||||||
| and other warrants | - | 84,000 | - | - | ||||||||||||
| Denominator for diluted earnings (loss) per | ||||||||||||||||
| share--adjusted weighted average shares | 12,919,000 | 12,750,000 | 12,853,000 | 12,666,000 | ||||||||||||
| Basic earnings (loss) per share | $ | (0.02 | ) | $ | 0.01 | $ | (0.08 | ) | $ | (0.02 | ) | |||||
| Diluted earnings (loss) per share | $ | (0.02 | ) | $ | 0.01 | $ | (0.08 | ) | $ | (0.02 | ) | |||||
Options and warrants to purchase 1,897,025 shares of common stock for the three months and nine months ended September 30, 2015, respectively, were not included in the denominator for diluted earnings (loss) per share because their effect would be antidilutive or because the shares were deemed contingently issuable. Options and warrants to purchase 1,087,333 shares and 1,075,565 shares of common stock for the three months and nine months ended September 30, 2014, respectively, were not included in the denominator for diluted earnings (loss) per share because their effect would be antidilutive or because the shares were deemed contingently issuable.
| 5 |
| Note 3-- | Fair Value of Financial Instruments |
Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels:
| Level 1: | Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. |
| Level 2: | Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets or similar assets or liabilities in markets that are not active. |
| Level 3: | Unobservable inputs that reflect the reporting entity's own assumptions. |
The carrying amount and fair value of the Company's financial instruments are approximately as follows:
| Description | Carrying Value | Fair Value | Level 1 | Level 2 | Level 3 | |||||||||||||||
| September 30, 2015 | ||||||||||||||||||||
| Long-term debt | $ | 4,093,149 | $ | 4,093,149 | - | $ | 4,093,149 | - | ||||||||||||
| Note receivable | 1,757,740 | 2,020,000 | - | 2,020,000 | - | |||||||||||||||
| Marketable securities | 263,000 | 263,000 | $ | 263,000 | - | - | ||||||||||||||
| December 31, 2014 | ||||||||||||||||||||
| Long-term debt | $ | 4,244,690 | $ | 4,244,690 | - | $ | 4,244,690 | - | ||||||||||||
| Note receivable | 1,829,827 | 2,098,000 | - | 2,098,000 | - | |||||||||||||||
| Marketable securities | 284,000 | 284,000 | $ | 284,000 | - | - | ||||||||||||||
Long-term debt: The fair value of the Company's term and revolver loans approximate carrying value as these loans were incurred within the current year and have variable market-based interest rates which reset every thirty days. The fair value of the Company's obligation for the acquisition of its lunasin technology license approximates carrying value as this obligation is a zero-interest based obligation discounted utilizing an interest rate factor comparable to the Company's market-based interest rate for its term and revolver loans. The fair value of the Company's notes payable obligations approximates carrying value as these obligations were incurred within the current year and have variable market-based interest rates which reset every ninety days.
Note receivable: The Company's note receivable is a variable rate residential mortgage-based financial instrument. An average of published interest rate quotes for a fifteen-year residential jumbo mortgage, a comparable financial instrument, was used to estimate fair value of this note receivable under a discounted cash flow model.
Marketable securities: The assets (trading securities) of the Company's Supplemental Executive Retirement Plan are recorded at fair value on a recurring basis, and are presented within Other Assets in the consolidated balance sheets.
The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of their respective balances.
| 6 |
| Note 4-- | Debt |
| September 30 | December 31 | |||||||
| 2015 | 2014 | |||||||
| Term loan | $ | 3,249,501 | $ | 3,067,442 | ||||
| Revolving line of credit | - | 500,000 | ||||||
| Notes payable | 356,787 | - | ||||||
| Obligation for acquisition of technology license, net | 486,861 | 677,248 | ||||||
| 4,093,149 | 4,244,690 | |||||||
| Less current portion | 813,560 | 697,423 | ||||||
| Total long-term debt | $ | 3,279,589 | $ | 3,547,267 | ||||
Estimated maturities of debt at September 30, 2015 are as follows:
| Twelve months ending September 30, | ||||
| 2016 | $ | 813,560 | ||
| 2017 | 680,008 | |||
| 2018 | 2,599,581 | |||
| $ | 4,093,149 |
On September 30, 2015, the Company entered into a series of lending agreements with a new primary lender which include agreements for a $3.25 million term loan and a $3.5 million revolving credit facility. These lending agreements replace similar borrowings under agreements with the Company’s former primary lender.
The new $3.25 million term loan is for a period of three years and requires monthly term loan payments, under a ten-year amortization, consisting of principal of $27,080 plus interest with a balloon payment for the outstanding balance due and payable on September 30, 2018. The term loan's interest rate is based on the 30-day LIBOR plus 2.25% and was 2.45% at September 30, 2015.
The new $3.5 million revolving line of credit agreement accrues interest at a floating interest rate based on the 30-day LIBOR plus 2.25% and has a maturity date of September 30, 2016. As of September 30, 2015, there were no outstanding borrowings on the revolving line of credit.
The proceeds from the new $3.25 million term loan were used to pay off the outstanding term loan and revolving line of credit balances, plus accrued interest, due under loan agreements with the Company’s former primary lender.
Borrowings under the new lending agreements are secured by all tangible and intangible assets of the Company, a whole life insurance policy on the life of the Company’s Chief Executive Officer, and by a mortgage on the real estate of the Company’s headquarters. The new lending agreements also include a covenant requiring the Company to maintain net tangible worth of not less than $9.5 million.
A description of the notes payable is presented in Note 5 -- Long-Term Incentive Compensation Plan.
| 7 |
| Note 5-- | Long-Term Incentive Compensation Plan |
In July 2010, the Company’s Reliv Europe subsidiary entered into a long-term performance-based incentive compensation agreement with the subsidiary’s senior managers. The valuation of the compensation agreement is an EBITDA-based formula derived from the subsidiary’s financial performance and vests in 20% annual increments which began in April 2011. The amount of the incentive, if any, can increase or decrease each quarter in accordance with a 24-month look-back of the subsidiary’s financial performance and the vesting provisions. Upon initial vesting, a manager may elect to exercise his/her put option to receive in cash some or all of his/her respective share of the incentive. For the three months and nine months ended September 30, 2015, compensation expense associated with this incentive plan was $-0- and $90,800, respectively. For the three months and nine months ended September 30, 2014, compensation expense associated with this incentive plan was $54,000 and $186,700, respectively. This compensation expense is presented in Selling, General and Administrative in the accompanying condensed consolidated statements of net income (loss) and comprehensive income (loss). At December 31, 2014, accrued compensation for this incentive plan was $666,000 and was presented in "Payroll, Payroll Taxes, and Incentive Compensation Payable" in the accompanying condensed consolidated balance sheets.
During the second quarter of 2015, the cumulative incentive amount of $756,800 became 100% vested, and concurrently, each of the subsidiary's senior managers exercised 100% of his/her put option. In the aggregate, the Company and the managers agreed to settle the incentive obligation whereby the Company will: issue notes payable of approximately $424,000, issue 100,000 shares of Company common stock (fair value at settlement of $117,000), and make cash payments of approximately $216,000.
The notes payable were issued by the Company to the managers in the second quarter of 2015 and range in length from one to two years with payments of principal and interest due quarterly beginning July 29, 2015. Each of the notes accrue interest at a floating interest rate based on the three-month pound LIBOR rate plus 3%. The interest rate at September 30, 2015 was 3.57906%. The aforementioned issuance of 100,000 shares of Company common stock and cash payments of approximately $216,000 occurred in the third quarter of 2015.
| Note 6-- | Taxes |
The interim financial statement provision for income taxes (benefit) is different from the amounts computed by applying the United States federal statutory income tax rate of 34%. In summary, the reasons for these differences are as follows:
| Nine months ended September 30 | ||||||||
| 2015 | 2014 | |||||||
| Income taxes (benefit) at U.S. statutory rate | $ | (439,000 | ) | $ | (152,000 | ) | ||
| State income taxes, net of federal benefit | 36,000 | 25,000 | ||||||
| Higher / (lower) effective taxes on earnings/losses | ||||||||
| in certain foreign countries | 39,000 | (6,000 | ) | |||||
| Foreign corporate income taxes | 32,000 | 8,000 | ||||||
| Other, net | 59,000 | (48,000 | ) | |||||
| $ | (273,000 | ) | $ | (173,000 | ) | |||
One of the Company's foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $800,000 plus interest at 20% per annum) in value-added tax (VAT) and withholding tax for the years 2004 through 2006. The Company, in consultation with its legal counsel, believes that there are strong legal grounds that it is not liable to pay the majority of the alleged tax deficiencies. As of December 31, 2010, management estimated and reserved approximately $185,000 in taxes and interest for resolution of this matter and recorded this amount within Selling, General, and Administrative expense in the 2010 Consolidated Statement of Income. In 2011, the Company made good faith deposits to the local tax authority under the tax agency's administrative judicial resolution process. As of September 30, 2015 and December 31, 2014, management's estimated reserve (net of deposits) for this matter is approximately $136,000 and $122,000, respectively. There has been no change in this matter during the first nine months of 2015.
| Note 7-- | Recent Accounting Standard Pending Adoption |
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09,Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The standard is effective for fiscal years beginning after December 15, 2017. The new standard permits the use of either the retrospective or modified retrospective transition method. The Company is currently evaluating the effect, if any, that the updated standard will have on its consolidated financial statements and related disclosures, as well its planned transition method.
In August 2014, the FASB issued ASU No. 2014-15,Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which requires management to assess, at each annual and interim reporting period, the entity's ability to continue as a going concern within one year from the date the financial statements are issued and provide related disclosures. The new standard will be effective for the Company for the annual reporting period ending December 31, 2016, with early adoption permitted. This standard is not currently expected to have a material effect on the Company's financial statement disclosures upon adoption, though the ultimate impact will be dependent on the Company's financial condition and expected operating outlook at such time.
| 8 |
FORWARD-LOOKING STATEMENTS
This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this annual report to conform such statements to actual results or to changes in our opinions or expectations.
Item No. 2 - Management’s Discussion and Analysis of FinancialCondition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis discusses the financial condition and results of our operations on a consolidated basis, unless otherwise indicated.
Overview
We are a developer, manufacturer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. We sell our products through an international network marketing system utilizing independent distributors. Sales in the United States represented approximately 78.1% of worldwide net sales for the nine months ended September 30, 2015 and 75.0% of worldwide net sales for the nine months ended September 30, 2014. Our international operations currently generate sales through distributor networks with facilities in Australia, Canada, Indonesia, Malaysia, Mexico, the Philippines, and the United Kingdom. We also operate in Ireland, France, Germany, Austria and the Netherlands from our United Kingdom distribution center, in New Zealand from our Australia office, and in Singapore from our Malaysia office.
We derive our revenues principally through product sales made by our global independent distributor base, which, as of September 30, 2015, consisted of approximately 45,890 distributors. Our sales can be affected by several factors, including our ability to attract new distributors and retain our existing distributor base, our ability to properly train and motivate our distributor base and our ability to develop new products and successfully maintain our current product line.
All of our sales to distributors outside the United States are made in the respective local currency; therefore, our earnings and cash flows are subject to fluctuations due to changes in foreign currency rates as compared to the U.S. dollar. As a result, exchange rate fluctuations may have an effect on sales and gross margins. U.S. generally accepted accounting practices require that our results from operations be converted to U.S. dollars for reporting purposes. Consequently, our reported earnings from foreign operations may be significantly affected by fluctuations in currency exchange rates, generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar. Products manufactured by us for sale to our foreign subsidiaries are transacted in U.S. dollars. From time to time, we enter into foreign exchange forward contracts to mitigate our foreign currency exchange risk.
Components of Net Sales and Expense
Product sales represent the actual product purchase price typically paid by our distributors, after giving effect to distributor allowances, which can range from 20% to 40% of suggested retail price, depending on the rank of a particular distributor. Handling and freight income represents the amounts billed to distributors for shipping costs. We record net sales and the related commission expense when the merchandise is shipped.
Our primary expenses include cost of products sold, distributor royalties and commissions and selling, general and administrative expenses.
| 9 |
Cost of products sold primarily consists of expenses related to raw materials, labor, quality control and overhead directly associated with production of our products and sales materials, as well as shipping costs relating to the shipment of products to distributors, and duties and taxes associated with product exports. Cost of products sold is impacted by the cost of the ingredients used in our products, the cost of shipping distributors’ orders, along with our efficiency in managing the production of our products.
Distributor royalties and commissions are monthly payments made to distributors based on products sold in their downline organization. Based on our distributor agreements, these expenses have typically approximated 23% of sales at suggested retail. Wholesale pricing discounts on distributor orders are based on the retail value of the product. Distributor royalties and commissions are paid on an amount referred to as the business value (“BV”), which is approximately 90% of the retail price of each product. Also, we include other sales leadership bonuses, such as Ambassador bonuses, within this caption. Overall, distributor royalties and commissions remain directly related to the level of our sales and should continue at comparable levels as a percentage of net sales going forward.
Selling, general and administrative expenses include the compensation and benefits paid to our employees, except for those in manufacturing, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses. These other corporate administrative expenses include professional fees, non-manufacturing depreciation and amortization, occupancy costs, communication costs and other similar operating expenses. Selling, general and administrative expenses can be affected by a number of factors, including staffing levels and the cost of providing competitive salaries and benefits; the amount we decide to invest in distributor training and motivational initiatives; and the cost of regulatory compliance.
Results of Operations
Net Sales.Overall net sales decreased by 14.8% in the three months ended September 30, 2015 compared to the same period in 2014. During the third quarter of 2015 (“Q3 2015”), sales in the United States decreased by 10.8%, and international sales decreased by 27.7% over the prior-year period. International sales, when reported in U.S. dollars, were negatively impacted by a stronger U.S. dollar versus all of the currencies of the markets where we do business. Excluding the impact of currency exchange fluctuation, international sales decreased by 18.4%.
The following table summarizes net sales by geographic market for the three months ended September 30, 2015 and 2014.
| Three months ended September 30, | ||||||||||||||||||||||||
| 2015 | 2014 | Change from prior year | ||||||||||||||||||||||
| Amount | % of Net Sales | Amount | % of Net Sales | Amount | % | |||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||
| United States | $ | 9,759 | 80.0 | % | $ | 10,946 | 76.5 | % | $ | (1,187 | ) | (10.8 | )% | |||||||||||
| Australia/New Zealand | 283 | 2.3 | 399 | 2.8 | (116 | ) | (29.1 | ) | ||||||||||||||||
| Canada | 260 | 2.2 | 346 | 2.4 | (86 | ) | (24.9 | ) | ||||||||||||||||
| Mexico | 136 | 1.1 | 192 | 1.3 | (56 | ) | (29.2 | ) | ||||||||||||||||
| Europe | 1,304 | 10.7 | 1,956 | 13.7 | (652 | ) | (33.3 | ) | ||||||||||||||||
| Asia | 452 | 3.7 | 475 | 3.3 | (23 | ) | (4.8 | ) | ||||||||||||||||
| Consolidated total | $ | 12,194 | 100.0 | % | $ | 14,314 | 100.0 | % | $ | (2,120 | ) | (14.8 | )% | |||||||||||
| 10 |
The following table summarizes net sales by geographic market for the nine months ended September 30, 2015 and 2014.
| Nine months ended September 30, | ||||||||||||||||||||||||
| 2015 | 2014 | Change from prior year | ||||||||||||||||||||||
| Amount | % of Net Sales | Amount | % of Net Sales | Amount | % | |||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||
| United States | $ | 30,831 | 78.1 | % | $ | 32,453 | 75.0 | % | $ | (1,622 | ) | (5.0 | )% | |||||||||||
| Australia/New Zealand | 984 | 2.5 | 1,261 | 2.9 | (277 | ) | (22.0 | ) | ||||||||||||||||
| Canada | 1,028 | 2.6 | 993 | 2.3 | 35 | 3.5 | ||||||||||||||||||
| Mexico | 567 | 1.4 | 607 | 1.4 | (40 | ) | (6.6 | ) | ||||||||||||||||
| Europe | 4,651 | 11.8 | 6,529 | 15.1 | (1,878 | ) | (28.8 | ) | ||||||||||||||||
| Asia | 1,413 | 3.6 | 1,412 | 3.3 | 1 | 0.1 | ||||||||||||||||||
| Consolidated total | $ | 39,474 | 100.0 | % | $ | 43,255 | 100.0 | % | $ | (3,781 | ) | (8.7 | )% | |||||||||||
The following table sets forth, as of September 30, 2015 and 2014, the number of our active distributors and Master Affiliates and above. The total number of active distributors includes Master Affiliates and above. We define an active distributor as one that enrolls as a distributor or renews his or her distributorship during the prior twelve months. Master Affiliates and above are distributors that have attained the highest level of discount and are eligible for royalties generated by Master Affiliate groups in their downline organization. The active distributor count for Europe includes our preferred customers in France. This program began in mid-2013 and the Europe active distributor count as of September 30, 2015 and 2014 includes 3,106 and 2,822 preferred customers, respectively.
| September 30, 2015 | September 30, 2014 | % Change | ||||||||||||||||||||||
| Active Distributors | Master Affiliates and Above | Active Distributors | Master Affiliates and Above | Active Distributors | Master Affiliates and Above | |||||||||||||||||||
| United States | 33,360 | 4,500 | 35,680 | 5,240 | (6.5 | )% | (14.1 | )% | ||||||||||||||||
| Australia/New Zealand | 1,210 | 130 | 1,290 | 150 | (6.2 | ) | (13.3 | ) | ||||||||||||||||
| Canada | 1,250 | 230 | 1,250 | 260 | — | (11.5 | ) | |||||||||||||||||
| Mexico | 1,240 | 100 | 1,140 | 140 | 8.8 | (28.6 | ) | |||||||||||||||||
| Europe | 6,390 | 630 | 8,060 | 920 | (20.7 | ) | (31.5 | ) | ||||||||||||||||
| Asia | 2,440 | 300 | 2,000 | 320 | 22.0 | (6.3 | ) | |||||||||||||||||
| Consolidated total | 45,890 | 5,890 | 49,420 | 7,030 | (7.1 | )% | (16.2 | )% | ||||||||||||||||
| 11 |
The following table provides key statistics related to distributor activity by market and should be read in conjunction with the following discussion.
Distributor Activity by Market
| International | ||||||||||||||||||||||||||||
| United States | AUS/NZ | Canada | Mexico | Europe | Asia | — Total | ||||||||||||||||||||||
| Three Months Ended 9/30/15 | ||||||||||||||||||||||||||||
| Sales in Q3 2015 in USD (in 000's) | $ | 9,759 | $ | 283 | $ | 260 | $ | 136 | $ | 1,304 | $ | 452 | $ | 2,435 | ||||||||||||||
| % change in sales-Q3 2015 vs. Q3 2014: | ||||||||||||||||||||||||||||
| in USD | -10.8 | % | -29.1 | % | -24.9 | % | -29.2 | % | -33.3 | % | -4.8 | % | -27.7 | % | ||||||||||||||
| due to currency fluctuation | - | -20.3 | % | -16.8 | % | -20.1 | % | -4.9 | % | -8.3 | % | -9.3 | % | |||||||||||||||
| Sales in local currency | -10.8 | % | -8.8 | % | -8.1 | % | -9.1 | % | -28.4 | % | 3.5 | % | -18.4 | % | ||||||||||||||
| # of new distributors-Q3 2015(1) | 2,135 | 78 | 79 | 134 | 591 | 336 | 1,218 | |||||||||||||||||||||
| # of new distributors-Q3 2014 | 2,253 | 120 | 75 | 132 | 870 | 273 | 1,470 | |||||||||||||||||||||
| % change | -5.2 | % | -35.0 | % | 5.3 | % | 1.5 | % | -32.1 | % | 23.1 | % | -17.1 | % | ||||||||||||||
| # of new Master Affiliates-Q3 2015 | 249 | 7 | 9 | 4 | 28 | 36 | 84 | |||||||||||||||||||||
| # of new Master Affiliates-Q3 2014 | 221 | 8 | 12 | 8 | 72 | 19 | 119 | |||||||||||||||||||||
| % change | 12.7 | % | -12.5 | % | -25.0 | % | -50.0 | % | -61.1 | % | 89.5 | % | -29.4 | % | ||||||||||||||
| # of Product orders-Q3 2015 | 41,888 | 2,011 | 1,141 | 924 | 5,256 | 2,991 | 12,323 | |||||||||||||||||||||
| # of Product orders-Q3 2014 | 46,018 | 2,236 | 1,148 | 931 | 5,697 | 3,303 | 13,315 | |||||||||||||||||||||
| % change | -9.0 | % | -10.1 | % | -0.6 | % | -0.8 | % | -7.7 | % | -9.4 | % | -7.5 | % | ||||||||||||||
| International | ||||||||||||||||||||||||||||
| United States | AUS/NZ | Canada | Mexico | Europe | Asia | — Total | ||||||||||||||||||||||
| Nine Months Ended 9/30/15 | ||||||||||||||||||||||||||||
| Sales in YTD 2015 in USD (in 000's) | $ | 30,831 | $ | 984 | $ | 1,028 | $ | 567 | $ | 4,651 | $ | 1,413 | $ | 8,643 | ||||||||||||||
| % change in sales-YTD 2015 vs. YTD 2014: | ||||||||||||||||||||||||||||
| in USD | -5.0 | % | -22.0 | % | 3.5 | % | -6.6 | % | -28.8 | % | 0.1 | % | -20.0 | % | ||||||||||||||
| due to currency fluctuation | - | -15.6 | % | -15.5 | % | -17.4 | % | -6.4 | % | -4.3 | % | -8.6 | % | |||||||||||||||
| Sales in local currency | -5.0 | % | -6.4 | % | 19.0 | % | 10.8 | % | -22.4 | % | 4.4 | % | -11.4 | % | ||||||||||||||
| # of new distributors-YTD 2015(1) | 6,495 | 204 | 341 | 515 | 2,499 | 888 | 4,447 | |||||||||||||||||||||
| # of new distributors-YTD 2014 | 6,450 | 281 | 245 | 398 | 3,863 | 600 | 5,387 | |||||||||||||||||||||
| % change | 0.7 | % | -27.4 | % | 39.2 | % | 29.4 | % | -35.3 | % | 48.0 | % | -17.4 | % | ||||||||||||||
| # of new Master Affiliates-YTD 2015 | 937 | 25 | 62 | 21 | 156 | 108 | 372 | |||||||||||||||||||||
| # of new Master Affiliates-YTD 2014 | 772 | 23 | 50 | 36 | 322 | 54 | 485 | |||||||||||||||||||||
| % change | 21.4 | % | 8.7 | % | 24.0 | % | -41.7 | % | -51.6 | % | 100.0 | % | -23.3 | % | ||||||||||||||
| # of Product orders-YTD 2015 | 128,602 | 6,117 | 3,892 | 3,162 | 18,195 | 8,496 | 39,862 | |||||||||||||||||||||
| # of Product orders-YTD 2014 | 138,634 | 6,624 | 3,454 | 2,900 | 20,017 | 10,175 | 43,170 | |||||||||||||||||||||
| % change | -7.2 | % | -7.7 | % | 12.7 | % | 9.0 | % | -9.1 | % | -16.5 | % | -7.7 | % | ||||||||||||||
| (1) | The new distributor totals in Europe for Q3 2015 and Q3 2014 include 347 and 443, respectively, new preferred customers in France. The nine-month YTD totals for 2015 and 2014 include 1,563 and 1,676, respectively, new preferred customers in France. |
| 12 |
United States
| · | Net sales decreased in the United States in Q3 2015 compared to the prior-year quarter as the result of declining distributor enrollments and ordering frequency, coupled by the decrease in the number of active distributors in the United States. |
| · | Flagship products in the LunaRich line, including Reliv Now® and LunaRich X™, constituted 18.9% and 15.8% of net sales in the United States, respectively, in Q3 2015 as our marketing focuses on these two products. For the nine months ended September 30, 2015, sales of Reliv Now and LunaRich X represented 19.0% and 15.4%, respectively, of net sales in the United States. |
| · | Distributor enrollments decreased by 5.2% and new Master Affiliate qualifications increased by 12.7% in Q3 2015 compared to the prior-year quarter. We continue to increase the focus on the business opportunity in 2015; however, our efforts to improve these key metrics have not taken hold at the pace expected. |
| · | Distributor retention was 71.0% in the first nine months of 2015 compared to 65.9% for all of 2014. Distributor retention is determined by the percentage of active distributors from 2014 that renewed their distributorships in 2015. |
| · | Our average order size in Q3 2015 increased by 0.3% to $323 at suggested retail value compared to the prior-year quarter; however, the number of product orders in Q3 2015 decreased by 9.0% compared to the prior-year quarter. |
International Operations
| · | The average foreign exchange rate for the U.S. dollar for the first nine months of 2015 was stronger versus the various local currencies in which we conduct business when compared with the average exchange rates for the same period in 2014, impacting sales negatively by 9.3% in Q3 2015 and by 8.6% for the nine months ended September 30, 2015. |
| · | Sales in Canada decreased by 8.1% in local currency in Q3 2015, as the average order size in Canada dropped by 8.8% compared to the prior-year quarter to C$420 at suggested retail in Q3 2015. |
| · | Sales in Mexico decreased by 9.1% in local currency in Q3 2015. Sales and the average order size in Mexico in Q3 2015 were negatively impacted subsequent to the implementation of a value added tax in Mexico on July 1, 2015. |
| · | Sales in Europe decreased by 28.4% in local currency in Q3 2015 compared to the prior-year quarter. The decline was primarily in the UK as the result of the departure of certain key distributors and a 20.7% decline in the number of active distributors in the European region overall. |
| · | Sales in Asia increased by 3.5% in local currency in Q3 2015 compared to the prior-year quarter. Minor increases in net sales in the Philippines, Singapore, and Indonesia were partially offset by a continued decline in Malaysia. Sales continue to be impaired in Malaysia as the result of a GST sales tax imposed in the country beginning April 1, 2015. |
| 13 |
Costs and Expenses
The following table sets forth selected results of our operations expressed as a percentage of net sales for the three- and nine-month periods ended September 30, 2015 and 2014. Our results of operations for the periods described below are not necessarily indicative of results of operations for future periods.
Income statement data
(amounts in thousands)
| Three months ended | ||||||||||||||||
| September 30, 2015 | September 30, 2014 | |||||||||||||||
| Amount | % of net sales | Amount | % of net sales | |||||||||||||
| Net sales | $ | 12,194 | 100.0 | % | $ | 14,314 | 100.0 | % | ||||||||
| Costs and expenses: | ||||||||||||||||
| Cost of products sold | 2,603 | 21.4 | 2,968 | 20.7 | ||||||||||||
| Distributor royalties and commissions | 4,309 | 35.3 | 4,985 | 34.8 | ||||||||||||
| Selling, general and adminstrative | 5,660 | 46.4 | 6,133 | 42.9 | ||||||||||||
| Income (loss) from operations | (378 | ) | (3.1 | ) | 228 | 1.6 | ||||||||||
| Interest income | 29 | 0.2 | 31 | 0.2 | ||||||||||||
| Interest expense | (37 | ) | (0.3 | ) | (26 | ) | (0.2 | ) | ||||||||
| Other income/(expense) | (72 | ) | (0.6 | ) | (60 | ) | (0.4 | ) | ||||||||
| Income (loss) before income taxes | (458 | ) | (3.8 | ) | 173 | 1.2 | ||||||||||
| Provision (benefit) for income taxes | (169 | ) | (1.4 | ) | 7 | - | ||||||||||
| Net income (loss) | $ | (289 | ) | (2.4 | )% | $ | 166 | 1.2 | % | |||||||
| Earnings (loss) per common share- Basic and Diluted | $ | (0.02 | ) | $ | 0.01 | |||||||||||
| Nine months ended | ||||||||||||||||
| September 30, 2015 | September 30, 2014 | |||||||||||||||
| Amount | % of net sales | Amount | % of net sales | |||||||||||||
| Net sales | $ | 39,474 | 100.0 | % | $ | 43,255 | 100.0 | % | ||||||||
| Costs and expenses: | ||||||||||||||||
| Cost of products sold | 8,246 | 20.9 | 8,855 | 20.5 | ||||||||||||
| Distributor royalties and commissions | 14,049 | 35.6 | 15,426 | 35.7 | ||||||||||||
| Selling, general and adminstrative | 18,245 | 46.2 | 19,391 | 44.8 | ||||||||||||
| Loss from operations | (1,066 | ) | (2.7 | ) | (417 | ) | (1.0 | ) | ||||||||
| Interest income | 89 | 0.2 | 100 | 0.2 | ||||||||||||
| Interest expense | (88 | ) | (0.2 | ) | (76 | ) | (0.1 | ) | ||||||||
| Other income/(expense) | (227 | ) | (0.6 | ) | (54 | ) | (0.1 | ) | ||||||||
| Loss before income taxes | (1,292 | ) | (3.3 | ) | (447 | ) | (1.0 | ) | ||||||||
| Benefit from income taxes | (273 | ) | (0.7 | ) | (173 | ) | (0.4 | ) | ||||||||
| Net loss | $ | (1,019 | ) | (2.6 | )% | $ | (274 | ) | (0.6 | )% | ||||||
| Loss per common share-Basic and Diluted | $ | (0.08 | ) | $ | (0.02 | ) | ||||||||||
| 14 |
Cost of Products Sold:
| · | The cost of products sold as a percentage of net sales in the first nine months of 2015 (“YTD 2015”) increased slightly compared to the prior-year period. The cost of shipping distributor orders in the United States increased slightly in YTD 2015 compared to the prior-year period, coupled with lower plant utilization and slightly higher production expenses in YTD 2015 versus the prior-year period. The cost of products sold as a percentage of net sales in Q3 2015 was negatively impacted by the same reasons as YTD 2015. |
Distributor Royalties and Commissions:
| · | Distributor royalties and commissions as a percentage of net sales for YTD 2015 compared to the prior-year period remained steady. The slight decrease is primarily the result of a lower payout of wholesale commissions as a percentage of net sales. The average order size of U.S. orders increased by 3.8% for YTD 2015, indicating that distributor orders were placed at a higher discount level in YTD 2015. Under our compensation plan, this results in a smaller wholesale commission payout. |
Selling, General and Administrative Expenses:
| · | Selling, general and administrative expenses declined by $473,000 in the third quarter of 2015 (“Q3 2015”) compared to the same period in 2014, and declined by $1.15 million in YTD 2015 compared to the prior-year period. |
| · | Salaries, salary-related expenses, and incentive compensation decreased in the aggregate by $452,000 in YTD 2015, compared to the prior-year period. Salaries decreased as the result of headcount reductions in the United States in the latter half of 2014 due to attrition and a voluntary retirement incentive. |
| · | Other general and administrative expenses decreased by $271,000 in YTD 2015 vs. the prior-year period. |
| o | Compensation expense recognized as part of a long-term incentive agreement with our management team in our European subsidiary decreased in YTD 2015 by $96,000 compared to the valuation in the prior-year period. During Q2 2015, this long-term incentive agreement became 100% vested and the participants exercised their put option in the agreement. This incentive agreement is described in Note 5 of the Condensed Consolidated Financial Statements. |
| o | Travel expenses decreased by $131,000 as part of an effort to reduce travel outside of sales events. |
| o | Consulting fees decreased by $55,000 in YTD 2015 compared to the prior-year period. |
Offsetting increases in other G&A expenses include:
| o | Property tax expense increased $75,000 compared to the prior year. In 2014, we received a credit on our property taxes as the result of successful appeals on our headquarters property for several prior years. |
| o | In Mexico, we recognized expense of approximately $130,000 during Q2 2015 related to the write-off of VAT credits and VAT paid on behalf of our distributors as part of an amnesty agreement related to the implementation of a new VAT arrangement in that country. |
| · | Sales and marketing expenses decreased by $352,000 in YTD 2015 versus the same period in 2014. Components of the decrease include: |
| o | $168,000 decrease in Star Director and other distributor bonuses, credit card fees, and other expenses related to the level of sales. |
| o | $198,000 decrease in promotional expenses in YTD 2015. |
Offsetting increases include:
| o | $139,000 increase in distributor conferences and meeting expenses. In YTD 2015, we held two regional distributor conferences, and we also resumed our quarterly Master Affiliate Training School program for distributors after a two year absence. Additionally, the cost of our international distributor conference, held this August in St. Louis, was more expensive than the international conference held in the prior-year third quarter. |
Other Income/Expense:
| · | The net expense in YTD 2015 is primarily the result of foreign currency exchange losses on intercompany debt denominated in U.S. dollars in certain of our subsidiaries. |
Income Taxes/Benefit:
| · | We reported an income tax benefit of $273,000 for YTD 2015, an effective benefit rate of 21.1%. |
| · | Our effective benefit rate was lower than the U.S. statutory rate of 34% due to the impact of the non-deductible operating loss in the Philippines and income taxes incurred in other foreign countries. In addition, we recognized state income tax expense due to our separate company filing status in several states. |
| 15 |
| · | See Note 6 of the Condensed Consolidated Financial Statements for additional detail regarding income taxes, including a reconciliation of the income tax benefit to the U.S. statutory rate for each period. |
Net Income:
| · | We recognized a larger net loss in the third quarter of 2015 and the nine-month period of 2015 when compared to the same periods in 2014 as the result of the decline in net sales in the United States and Europe, coupled with the expenses recognized in Mexico as part of the new VAT implementation and amnesty program. |
Financial Condition, Liquidity and Capital Resources
During the first nine months of 2015, we used $1.10 million of net cash in operating activities, $145,000 was used in investing activities, and we used $585,000 in financing activities. This compares to $720,000 of net cash used in operating activities, $694,000 used in investing activities, and $9,000 used in financing activities in the same period of 2014. Cash and cash equivalents decreased by $1.83 million to $3.16 million as of September 30, 2015 compared to $4.99 million as of December 31, 2014.
Significant changes in working capital items consisted of an increase in inventory of $586,000, an increase in prepaid expenses/other current assets of $123,000, and an increase in refundable income taxes of $214,000 in the first nine months of 2015. The increase in inventory is the result of net sales being lower than forecasted in production schedules, and the increase in prepaid expenses/other current assets represents the annual premium payments made in the first quarter on most of the corporate business insurance policies. The increase in refundable income taxes is the result of the income tax benefit generated by our year-to-date net loss for 2015.
Investing activities during the first nine months of 2015 consisted of a net investment of $218,000 for capital expenditures, offset by payments received on a distributor note receivable of $72,000. Financing activities during the first nine months of 2015 consisted of the payoff on long-term and line of credit borrowings with our prior bank of $3.83 million, offset by proceeds of $3.25 million under borrowings from our new primary lender.
Stockholders’ equity decreased to $16.12 million at September 30, 2015 compared to $17.00 million at December 31, 2014. The decrease is primarily due to our net loss during the first nine months of 2015 of $1.02 million. Our working capital balance was $5.01 million at September 30, 2015 compared to $5.65 million at December 31, 2014. The current ratio was 1.95 at September 30, 2015, compared to 1.96 at December 31, 2014. The decline in our working capital balance at September 30, 2015 is primarily the result of the decrease in our cash balance.
On September 30, 2015, we entered into series of agreements with a new primary lender which include agreements for a $3.25 million term loan and a $3.5 million revolving credit facility. These lending agreements replace similar borrowings under agreements with our former primary lender.
The new $3.25 million term loan is for a period of three years and requires monthly term loan payments, under a ten-year amortization, consisting of principal of $27,080 plus interest with a balloon payment for the outstanding balance due and payable on September 30, 2018. The term loan's interest rate is based on the 30-day LIBOR plus 2.25% and was 2.45% at September 30, 2015.
The new $3.5 million revolving line of credit agreement accrues interest at a floating interest rate based on the 30-day LIBOR plus 2.25% and has a maturity date of September 30, 2016. As of September 30, 2015, there were no outstanding borrowings on the revolving line of credit.
The proceeds from the new $3.25 million term loan were used to pay off the outstanding term loan and revolving line of credit balances, plus accrued interest, due under loan agreements with our former primary lender. Borrowings under the new lending agreements are secured by all our tangible and intangible assets, a whole life insurance policy on the life of our Chief Executive Officer, and by a mortgage on the real estate of our headquarters. The new lending agreements also include a covenant requiring us to maintain net tangible worth of not less than $9.5 million beginning in December 2015.
| 16 |
Management believes that our cash on hand, internally generated funds, and the new bank loan facilities will be sufficient to meet working capital requirements and our debt service requirements for the next twelve months.
Critical Accounting Policies
A summary of our critical accounting policies and estimates is presented on pages 26-28 of our 2014 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2015. Our critical accounting policies remain unchanged as of September 30, 2015.
Item No. 4 - Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has reviewed and evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2015. Based on such review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of September 30, 2015, to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to our management, including the officers, as appropriate to allow timely decisions regarding required disclosure. There were no material changes in our internal control over financial reporting during the third quarter of 2015 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.
| 17 |
| Exhibit | ||
| Number | Document | |
| 10.1 | Promissory Note (term loan) dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith). | |
| 10.2 | Promissory Note (revolving credit facility) dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith). | |
| 10.3 | Business Loan Agreement dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith). | |
| 10.4 | Deed of Trust dated September 30, 2015 between Reliv International, Inc. as Grantor and Enterprise Bank & Trust (filed herewith). | |
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the | |
| Securities Exchange Act, as amended (filed herewith). | ||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the | |
| Securities Exchange Act, as amended (filed herewith). | ||
| 32 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. | |
| 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). | ||
| 101 | Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, formatted in XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss), (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to Condensed Consolidated Financial Statements. |
| 18 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
RELIV’ INTERNATIONAL, INC.
| By: | /s/ Robert L. Montgomery | |
| Robert L. Montgomery, Chairman of the Board of Directors and Chief Executive Officer |
Date: November 13, 2015
| By: | /s/ Steven D. Albright | |
| Steven D. Albright, Chief Financial Officer (and accounting officer) |
Date: November 13, 2015
| 19 |